A Call to Action Against Persistent Lack of Transparency in Vaccine Pricing Practices During the COVID-19 Pandemic
Lack of transparency in vaccine pricing practices is a problem that has been under discussion for a long time. To tackle this, the World Health Assembly adopted the resolution 'Improving the transparency of markets for medicines, vaccines, and other health products' in 2019. However, despi...
Saved in:
Main Author: | Gabriela Arguedas-Ramírez (Author) |
---|---|
Format: | Book |
Published: |
Ubiquity Press,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Price-Transparency and Cost Accounting
by: Peter Hilsenrath PhD, et al.
Published: (2015) -
Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule
by: Neelesh P Jain, et al.
Published: (2023) -
Price transparency in Iranian healthcare market
by: Ameneh Rahban, et al.
Published: (2024) -
Are payors ready for transparent prices yet?
by: Jasmin Barman-Aksözen
Published: (2022) -
Publicly Available Pricing Information for Orthopaedic Upper Extremity Procedures in the United States Lacks Transparency and Consistency Between Major Hospitals
by: M. Lane Moore, B.S, et al.
Published: (2022)